semaglutide alzheimer's phase 3 An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression of disease in closely watched trials, Novo Nordisk said. https://cnn.it/4ohnWx8 Ozempic linked to lower Alzheimer's
Description
A new study finds quitting GLP-1 drugs like Ozempic can reverse health gains and increase heart health risks
Alex and Pehek, 2007)
Not stopping completely
Automated approvals prioritize revenue over patient safety
Lower muscle mass with the same weight appears softer and less defined
